Correspondence
Outcome of SARS-CoV-2 associated Guillain-Barre syndrome depends on early treatment and vaccination
La evolución del síndrome de Guillain-Barré asociado al SARS-CoV-2 depende del tratamiento temprano y de la vacunación
J
Finsterer
1,*
,
F A
Scorza
2
Show Less
Affiliation
1
Klinik Landstrasse. Messerli Institute. Viena
, Austria
2
Escola Paulista de Medicine. Universidade Federal de São Paulo. São Paulo
, Brasil
*Correspondence: Dr. Josef Finsterer. Klinik Landstrasse. Messerli Institute. Juchgasse, 25. 1030 Viena, Austria. E-mail: fipaps@yahoo.de
Rev Neurol 2022
, 74(12),
408;
https://doi.org/10.33588/rn.7412.2021340
